ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transcatheter

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes and Severe Aortic Stenosis at High Risk for Surgery: An Analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve)
March 23, 2014
In this manuscript, the authors compare outcomes among patients from the PARTNER trial with diabetes who underwent surgical or transcatheter treatment. Among these patients with diabetes, 6-month and 1-year all cause mortality was lower in the transcatheter group compared with the surgical group. At 2 years this survival benefit was lost.
Stratification of Outcomes After Transcatheter Aortic Valve Replacement According to Surgical Inoperability for Technical Versus Clinical Reasons
March 12, 2014
In this manuscript the authors analyse data from the cohort B (inoperable patients) of the PARTNER trial in order to compare outcomes in two groups of patients, those inoperable for technical reasons and those inoperable for clinical reasons. Patients deemed inoperable for technical reasons had a lower risk profile.
Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Severely Stenotic Bicuspid Versus Tricuspid or Non bicuspid Valves
March 11, 2014
There have been some concerns about outcomes of TAVI in patients with bicuspid aortic valves (BAV). In this retrospective study, outcomes after TAVI in 21 patients with BAVs were compared with those in 447 patients with tricuspid aortic valves (TAV). Device success was lower and 30-day mortality was higher in BAV patients.
Post-procedural aortic regurgitation in balloon-expandable and self expandable TAVR procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry.
March 4, 2014
In this study, the authors evaluate the relevance of post-procedural-aortic-regurgitation (AR) following transcatheter aortic valve replacement (TAVR) in patients included in the FRANCE 2 registry. They compare outcomes and risk factors for post-procedural AR in balloon expandable (BE) and self-expandable (SE) prosthesis.
Transaortic Valvular Implantation
December 4, 2012
Transaortic valve replacement is an alternative to the transfemoral and transapical approaches in an 83-year old male with ischemic heart disease, severe peripheral artery disease and severe symptomatic aortic stenosis.
The Cardiovascular Hybrid OR-Clinical & Technical Considerations
April 10, 2011
In hybrid ORs angiographic 3D imaging capabilities are required. Due to the technical complexity and the multitude of users and procedures, careful planning is key for every hybrid room project.
Off-Pump Transapical Aortic Valve Implantation
December 17, 2008
STSA Surgical Motion Picture 2008 Annual Meeting

Pages

Submit Content